Free Trial
TSE:MBX

Microbix Biosystems (MBX) Stock Price, News & Analysis

Microbix Biosystems logo
C$0.29 -0.01 (-1.69%)
As of 03:42 PM Eastern

About Microbix Biosystems Stock (TSE:MBX)

Key Stats

Today's Range
C$0.29
C$0.31
50-Day Range
C$0.29
C$0.37
52-Week Range
C$0.28
C$0.55
Volume
33,873 shs
Average Volume
129,763 shs
Market Capitalization
C$38.19 million
P/E Ratio
11.05
Dividend Yield
2.30%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Stock News Headlines

Microbix & Bulgaria’s NCIPD Execute Supply Agreement
Microbix Biosystems Inc. (MBX.TO) - Yahoo Finance
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
Microbix Reports Results for Q2 Fiscal 2025
Microbix Reports Results for Q2 Fiscal 2025
Microbix & Aurevia Introduce Novel EQA Scheme
See More Headlines

MBX Stock Analysis - Frequently Asked Questions

Microbix Biosystems' stock was trading at C$0.41 at the beginning of 2025. Since then, MBX shares have decreased by 29.3% and is now trading at C$0.29.

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), NightHawk Biosciences (NHWK), Organigram (OGI), VEON (VEON) and Vaxart (VXRT).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:MBX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.03
Trailing P/E Ratio
11.24
Forward P/E Ratio
14.75
P/E Growth
N/A
Net Income
C$3.39 million
Net Margins
13.86%
Pretax Margin
N/A
Return on Equity
12.65%
Return on Assets
3.82%

Debt

Debt-to-Equity Ratio
22.61
Current Ratio
7.15
Quick Ratio
5.57

Sales & Book Value

Annual Sales
C$24.42 million
Price / Sales
1.59
Cash Flow
C$0.07 per share
Price / Cash Flow
4.13
Book Value
C$0.21 per share
Price / Book
1.43

Miscellaneous

Outstanding Shares
131,704,278
Free Float
N/A
Market Cap
C$38.85 million
Optionable
Not Optionable
Beta
0.34
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (TSE:MBX) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners